Phyllanthus niruri is a small tropical herb with a surprisingly long résumé in traditional medicine and a growing body of laboratory and clinical research behind it. Known by dozens of regional names, including “stonebreaker” (chanca piedra) in South America and “bhumyamalaki” in Ayurveda, the plant has been used for centuries across multiple healing traditions for kidney stones, liver complaints, and infections. Modern science has caught up with some of those uses, particularly regarding kidney stones, where human trials exist, while other traditional claims still rest mostly on animal and cell-culture work. The picture that emerges is a plant with genuinely interesting pharmacology, but one where the gap between laboratory promise and proven clinical benefit varies widely depending on which health condition you are looking at.
Getting the Right Plant
One of the first problems with Phyllanthus niruri is making sure you actually have Phyllanthus niruri. The genus Phyllanthus contains hundreds of species, and several of them look almost identical when dried and powdered. In India, where much of the global herb trade originates, four species in particular grow side by side: P. niruri (often called P. amarus in some classification systems), P. fraternus, P. debilis, and P. urinaria. Because they overlap geographically and resemble one another, dried herb shipments can contain the wrong species, whether through honest misidentification or deliberate substitution. Researchers have developed DNA-based markers specifically to tell these species apart in powdered form, because mixing them up does not just create a labeling problem; the species contain different chemical profiles and have different biological activities.1PubMed. SCAR markers for correct identification of Phyllanthus amarus, P. fraternus, P. debilis and P. urinaria used in scientific investigations and dry leaf bulk herb trade For anyone buying Phyllanthus niruri supplements, this means the source and quality control behind the product matters considerably.
Standardization efforts are underway. An HPLC method using corilagin as a chemical marker has been validated for identifying and grading both raw herb material and commercial extracts of P. niruri, giving manufacturers a practical tool for quality checks.2Biomedical Chromatography. Validated HPLC method for the standardization of Phyllanthus niruri (herb and commercial extracts) using corilagin as a phytochemical marker But not every supplement on the shelf has been run through such testing, so product quality remains uneven.
Kidney Stones and the “Stonebreaker” Reputation
The common name “stonebreaker” is not just folklore. Kidney stone research is arguably the area where Phyllanthus niruri has the strongest and most consistent evidence. The plant appears to interfere with calcium oxalate crystal formation at multiple stages. In vitro work has shown that an aqueous extract of P. niruri inhibits the growth and aggregation of calcium oxalate crystals in human urine, suggesting it could slow the earliest steps of stone formation.3PubMed. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro Separate animal studies found that the plant strongly inhibited the growth of implanted stone matrices and even dissolved stones in some treated animals.4PubMed. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation
The more compelling results come from human data. In a prospective, randomized trial, patients who took P. niruri after extracorporeal shock wave lithotripsy (the standard stone-blasting procedure) had a higher stone-free rate than those who did not, with the benefit reaching statistical significance for stones located in the lower part of the kidney. The researchers noted an “absolute lack of side effects” in the treatment group.5PubMed. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study Another clinical study tracked stone counts in patients taking P. niruri and found that average stones per patient dropped significantly over the treatment period.6PubMed Central. Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention
None of this means P. niruri replaces conventional urology. Large kidney stones still need procedural treatment, and the clinical trials have been relatively small. But for people prone to recurrent calcium oxalate stones, the combination of laboratory mechanism data and supportive human trials makes this one of the better-substantiated traditional uses of the plant.
Liver Protection
Traditional healers across South Asia and South America have long prescribed P. niruri for liver problems, and lab research has identified plausible mechanisms behind that tradition. In animal models of chemical liver damage, P. niruri extracts restored liver enzyme levels toward normal, reduced lipid peroxidation (a marker of oxidative damage to cell membranes), and boosted antioxidant enzyme activity. Histological examination of liver tissue in treated animals showed less inflammation and a more normal architecture compared to untreated animals with the same toxic exposure.7PubMed. Protein isolate from the herb, Phyllanthus niruri L. (Euphorbiaceae), plays hepatoprotective role against carbon tetrachloride induced liver damage via its antioxidant properties
A rat study of liver cirrhosis induced by a different toxin found that P. niruri treatment produced effects comparable to silymarin, the active compound in milk thistle, which is one of the most widely used liver-support supplements in the world. Treated rats had smoother liver surfaces, less fibrous tissue proliferation, and liver biochemistry closer to normal levels.8PubMed Central. Protective Role of Phyllanthus niruri Extract against Thioacetamide-Induced Liver Cirrhosis in Rat Model The comparison with silymarin is notable because it gives a concrete benchmark, though it should be stressed that these are still animal studies. Well-designed human trials of P. niruri for liver disease remain scarce.
The Hepatitis B Question
P. niruri generated considerable excitement in the late 1980s when a landmark study showed that an aqueous extract of the plant could inhibit hepatitis B virus DNA polymerase and bind to the virus’s surface antigen in laboratory settings.9PubMed Central. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies Further phytochemistry work identified specific lignans from the plant, including nirtetralin and its derivatives, that suppressed the secretion of hepatitis B antigens in cell cultures in a dose-dependent manner.10PubMed. Lignans with anti-hepatitis B virus activities from Phyllanthus niruri L.
When the concept moved to human testing, however, the results were disappointing. A randomized controlled trial comparing P. niruri to placebo in patients with chronic hepatitis B found no significant differences in viral load after 12 months, and no patients cleared the hepatitis B surface antigen. The trial was stopped at the end of its second year because there was no apparent benefit.11Complementary Medicine Research. Phyllanthus niruri versus Placebo for Chronic Hepatitis B Virus Infection: A Randomized Controlled Trial This is a useful cautionary tale: laboratory activity against a virus does not guarantee that the plant, taken orally at practical doses, will produce a meaningful clinical effect. The compounds may not reach the liver in sufficient concentrations, or the immune dynamics of chronic infection may be too complex for the plant’s mechanisms to overcome.
Blood Sugar, Blood Pressure, and Lipids
P. niruri has been investigated for several metabolic effects, with most data still coming from animal and cell studies rather than human trials. In the realm of blood sugar, P. niruri extracts have shown strong inhibition of alpha-glucosidase, the enzyme in the gut that breaks complex carbohydrates into absorbable sugars. Specific compounds responsible for this activity include corilagin and repandusinic acid A.12PubMed. Investigation of antidiabetic potential of Phyllanthus niruri L. using assays for α-glucosidase, muscle glucose transport, liver glucose production, and adipogenesis In a mouse model, a P. niruri extract significantly reduced post-meal blood sugar spikes compared to controls, with the effect kicking in roughly 90 minutes after the sugar load and persisting through the end of the experiment.13Phytomedicine Plus. Extraction of anti-hyperglycaemic bioactive compounds from Phyllanthus niruri L. through solvent mixture design: In vitro and in vivo evaluation
Blood pressure research has followed a similar pattern. In spontaneously hypertensive rats with induced diabetes, P. niruri extract lowered mean arterial blood pressure significantly over 14 and 28 days of treatment, with larger drops in the animals that started with higher pressure.14Annals of Clinical and Experimental Hypertension. Evaluation of In vivo Efficacy of Aqueous Leaf Extract of Phyllanthus Niruri in Diabetic Hypertensive Rats Mechanistic work has pointed to the nitric oxide signaling pathway and relaxation of blood vessel walls as contributing factors.15PubMed. Blood pressure lowering effect and vascular activity of Phyllanthus niruri extract: The role of NO/cGMP signaling pathway and β-adrenoceptor mediated relaxation of isolated aortic rings
On cholesterol, an animal study demonstrated that P. niruri extract lowered serum lipids in rats made hyperlipidemic, with the mechanism traced partly to reduced liver cholesterol production and increased bile acid excretion.16PubMed. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats These metabolic findings are interesting precisely because they touch on conditions, like type 2 diabetes and high blood pressure, that affect enormous populations worldwide. But none of them have yet been validated in controlled human trials, so it is premature to treat P. niruri as a substitute for blood pressure or diabetes medications.
Anti-Inflammatory and Antimicrobial Activity
Cell-culture studies have demonstrated that P. niruri extracts can dial down inflammatory signaling. In activated immune cells, the extracts reduced levels of the pro-inflammatory molecules TNF-alpha and IL-1β and inhibited the expression of COX-2 and iNOS, two enzymes that amplify inflammation.17PubMed. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway18HAYATI Journal of Biosciences. Anti-Inflammatory Activity of Phyllanthus niruri L. Leaf Extract: In Vitro Study on RAW 264.7 Macrophage Cells and In Silico Analysis This is broadly consistent with the traditional use of P. niruri for inflammatory complaints, though, again, in vitro results do not automatically translate to meaningful anti-inflammatory effects when a person drinks a tea or takes a capsule.
On the antimicrobial front, P. niruri extracts have shown activity against several bacteria in lab assays, including Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Klebsiella pneumoniae, and Bacillus cereus. Activity against Shigella species was weaker. Researchers have flagged the plant as a possible source of compounds worth developing further as antibiotics, given both the antibacterial activity and the low toxicity seen in the extracts tested.19PubMed Central. Phyllanthus niruri Linn.: Antibacterial Activity, Phytochemistry, and Enhanced Antibiotic Combinatorial Strategies The research is far from suggesting that P. niruri could replace antibiotics, but it is consistent with a tradition of using the plant topically or internally for infections.
Safety, Toxicity, and Drug Interactions
P. niruri is generally considered to have a good safety profile at normal doses, but “generally safe” deserves some qualification. An acute toxicity study of the aqueous leaf extract in rats found no toxicity at the doses tested and reported an LD50 above 5,000 mg per kilogram of body weight, which is a high bar.20PubMed Central. Acute toxicity studies of aqueous leaf extract of Phyllanthus niruri However, a separate study in Swiss albino mice found that at very high doses (above roughly 2,500 mg per kilogram of body weight), the plant raised urea levels and caused visible changes in kidney tissue.21Pharmacognosy Journal. Acute toxicity study of Phyllanthus niruri and its effect on the cyto-architectural structure of nephrocytes in Swiss albino mice Mus-musculus The practical takeaway is that typical supplement doses are unlikely to cause harm, but megadosing is unwise, and people with pre-existing kidney disease should be cautious.
Drug interactions are the bigger real-world concern. Phyllanthin, one of the plant’s key lignans, has been shown to inhibit P-glycoprotein (P-gp), a transporter protein that acts as a gatekeeper in the gut wall and influences how much of many prescription drugs gets absorbed into the bloodstream.22Journal of Pharmacy and Pharmacology. Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier Inhibiting P-gp can raise blood levels of drugs that are normally pumped back out of gut cells, potentially amplifying both their effects and their side effects. A recent analysis specifically flagged the potential for P. niruri to alter the bioavailability of rifampicin, a critical tuberculosis drug, through overlapping effects on P-gp and other transport and metabolic pathways.23PubMed. Potential Alteration of Rifampicin’s Bioavailability by Phyllanthus niruri Supplementation in Tuberculosis Therapy This is worth taking seriously: if you are on prescription medications, especially ones with narrow safety margins, talk to your doctor before adding P. niruri to the mix.
Key Compounds and Why Harvest Timing Matters
P. niruri contains a complex mix of bioactive compounds. Among the most studied are the lignans phyllanthin and hypophyllanthin, the tannin corilagin, and various flavonoids and phenolic acids. Phyllanthin and hypophyllanthin have attracted attention for their anticancer potential: laboratory work has shown these compounds can sensitize drug-resistant breast cancer cells to doxorubicin, a standard chemotherapy agent.24PubMed Central. Hypophyllanthin and Phyllanthin from Phyllanthus niruri Synergize Doxorubicin Anticancer Properties against Resistant Breast Cancer Cells Corilagin, as mentioned earlier, is both a key alpha-glucosidase inhibitor and the chemical marker used for standardizing commercial extracts.
The balance among these compounds shifts depending on when the plant is harvested. A metabolomics study comparing P. niruri at 8, 10, and 12 weeks of growth found that the eight-week-old plant had more phyllanthin and certain amino acids, while the 10-week-old plant was richer in hypophyllanthin and phenolic compounds. By 12 weeks, sugar content dominated. This matters because the biological activity of any extract depends on which compounds are most concentrated, and that depends on when the plant was picked. A supplement made from an early-harvested batch will have a different chemical fingerprint than one from a late-harvested batch, even if they come from the same field. Combined with the species-confusion problem discussed earlier, this helps explain why clinical results can be inconsistent and why standardization using chemical markers is not just a nice-to-have but a practical necessity.
Effects on Gut Health in Animal Models
Emerging research has looked at P. niruri’s effects on intestinal health, though so far only in poultry rather than humans. When added to the diet of broiler chickens, P. niruri powder increased the height of mucosal villi in the small intestine, which generally correlates with better nutrient absorption. However, at higher inclusion rates, the taller villi appeared fragile and some mucosal cell death was noted.25South African Journal of Animal Science. Evaluation of Phyllanthus niruri L. powder on growth performance, haematology, and intestinal morphology of broilers In laying hens, P. niruri leaf meal boosted populations of beneficial gut bacteria without adversely affecting blood parameters.26Federal Polytechnic Ilaro Journal of Pure And Applied Sciences. BLOOD PROFILE AND INTESTINAL MICROBES OF PULLET CHICKENS FED PHYLLANTHUS NIRURI LEAF MEAL These are animal agriculture studies, not human health trials, and chickens have a very different gut from ours. But they point to P. niruri as having prebiotic-like effects that may be worth exploring in mammals and, eventually, people.
Where the Evidence Stands and Where It Falls Short
The research landscape for P. niruri is uneven in a very specific way. For kidney stones, there are randomized human trials with real clinical endpoints, reasonable sample sizes, and consistent results pointing in the same direction as the lab work. For liver protection, the animal data is strong and mechanistically detailed, but human trials are thin. For hepatitis B, the science moved from promising lab results to a negative clinical trial, a useful reminder that laboratory activity does not guarantee real-world benefit. For metabolic effects like blood sugar and blood pressure, the evidence is still almost entirely preclinical. And for antimicrobial and anticancer properties, research is at the very earliest stages, mostly test-tube work identifying compounds of interest.
Pharmacokinetic modeling of P. niruri’s compounds suggests they are reasonably well absorbed and have low predicted liver toxicity, which is encouraging for future drug development.27Jurnal Mandala Pharmacon Indonesia. Combined Peperomia pellucida – Phyllanthus niruri Extracts: Pharmacokinetic, Target Prediction, and Total Phenolic Evaluation But “well absorbed” does not automatically mean “clinically effective,” and the gap between in-silico prediction and bedside reality can be wide. What P. niruri really needs at this stage is more well-powered clinical trials, particularly for liver disease and metabolic conditions where the preclinical signal is strong enough to justify the investment.